Vismodegib free base

Vismodegib free base 

To Order Contact us: lieven@wlsolutions.be

Masupirdine (free base)

HY-109118 1mg
EUR 223

R406 (free base)

HY-11108 10mM/1mL
EUR 231

ITI214 (free base)

HY-12501 100mg
EUR 2943

AS2863619 (free base)

HY-126675 5mg
EUR 1175

AZD3839 (free base)

HY-13438 50mg
EUR 1014

RPR107393 free base

HY-100299 1mg
EUR 481

FR167344 free base

HY-100301 1mg
EUR 2637

FR183998 free base

HY-100302 1mg
EUR 1127

FR194738 free base

HY-100303 1mg
EUR 1990

Vatalanib (free base)

HY-10203 5mg
EUR 119

YM158 (free base)

HY-U00355 1mg
EUR 2309

R406(free base)

E1KS1533 2mg
EUR 521

TMB free base

TB0954 1g
EUR 70.88

AZD4547, Free Base

ADC-P-063 unit Ask for price

AZD8055, Free Base

ADC-P-064 unit Ask for price

Cyclopamine, Free Base

ADC-P-079 unit Ask for price

Ixabepilone, Free Base

ADC-P-104 unit Ask for price

Xylazine (free base)

Q-1445.0025 25.0g
EUR 321
Description: Sum Formula: C12H16N2S; CAS# [7361-61-7]

R406 (free base)

A5880-100 100 mg
EUR 1210
Description: R406 is a potent SYK inhibitorSpleen tyrosine kinase (SYK) is a non-receptor tyrosine kinase mainly expressed in hematopoietic cells. It transmits signals from a variety of cell surface receptors including CD74, Fc receptor and integrins.

R406 (free base)

A5880-25 25 mg
EUR 514
Description: R406 is a potent SYK inhibitorSpleen tyrosine kinase (SYK) is a non-receptor tyrosine kinase mainly expressed in hematopoietic cells. It transmits signals from a variety of cell surface receptors including CD74, Fc receptor and integrins.

R406 (free base)

A5880-5 5 mg
EUR 166
Description: R406 is a potent SYK inhibitorSpleen tyrosine kinase (SYK) is a non-receptor tyrosine kinase mainly expressed in hematopoietic cells. It transmits signals from a variety of cell surface receptors including CD74, Fc receptor and integrins.

R406 (free base)

A5880-5.1 10 mM (in 1mL DMSO)
EUR 264
Description: R406 is a potent SYK inhibitorSpleen tyrosine kinase (SYK) is a non-receptor tyrosine kinase mainly expressed in hematopoietic cells. It transmits signals from a variety of cell surface receptors including CD74, Fc receptor and integrins.

R406 (free base)

A5880-S Evaluation Sample
EUR 81
Description: R406 is a potent SYK inhibitorSpleen tyrosine kinase (SYK) is a non-receptor tyrosine kinase mainly expressed in hematopoietic cells. It transmits signals from a variety of cell surface receptors including CD74, Fc receptor and integrins.

Rucaparib (free base)

A8893-10 10 mg
EUR 200
Description: Rucaparib, also named as AG-014699 or PF-01367338, is a poly (ADP ribose) polymerase (PARP) inhibitor. PARP is a DNA damage-activated nuclear enzyme that has a key signaling role in the base excision repair pathway.

Rucaparib (free base)

A8893-200 200 mg
EUR 1036
Description: Rucaparib, also named as AG-014699 or PF-01367338, is a poly (ADP ribose) polymerase (PARP) inhibitor. PARP is a DNA damage-activated nuclear enzyme that has a key signaling role in the base excision repair pathway.

Rucaparib (free base)

A8893-5 5 mg
EUR 137
Description: Rucaparib, also named as AG-014699 or PF-01367338, is a poly (ADP ribose) polymerase (PARP) inhibitor. PARP is a DNA damage-activated nuclear enzyme that has a key signaling role in the base excision repair pathway.

Rucaparib (free base)

A8893-5.1 10 mM (in 1mL DMSO)
EUR 142
Description: Rucaparib, also named as AG-014699 or PF-01367338, is a poly (ADP ribose) polymerase (PARP) inhibitor. PARP is a DNA damage-activated nuclear enzyme that has a key signaling role in the base excision repair pathway.

Rucaparib (free base)

A8893-50 50 mg
EUR 456
Description: Rucaparib, also named as AG-014699 or PF-01367338, is a poly (ADP ribose) polymerase (PARP) inhibitor. PARP is a DNA damage-activated nuclear enzyme that has a key signaling role in the base excision repair pathway.

LY2835219 free base

A3575-100 100 mg
EUR 572
Description: LY2835219 is an orally available cyclin-dependent kinase (CDK) inhibitor that targets the CDK4 (cyclin D1) and CDK6 (cyclin D3) cell cycle pathway, with potential antineoplastic activity.

LY2835219 free base

A3575-25 25 mg
EUR 258
Description: LY2835219 is an orally available cyclin-dependent kinase (CDK) inhibitor that targets the CDK4 (cyclin D1) and CDK6 (cyclin D3) cell cycle pathway, with potential antineoplastic activity.

LY2835219 free base

A3575-5 5 mg
EUR 142
Description: LY2835219 is an orally available cyclin-dependent kinase (CDK) inhibitor that targets the CDK4 (cyclin D1) and CDK6 (cyclin D3) cell cycle pathway, with potential antineoplastic activity.

Ruxolitinib (free base)

10-042 25 mg
EUR 348.5
Description: Antineoplastic, anti-inflammatory and immunomodulating agent. Orally bioavailable potent ATP mimetic that inhibits both JAK1 and JAK2 with IC50 values of 2.7 and 4.5nM, respectively and is less selective for JAK3 (IC50=322nM). Affects DC differentiation and function, leading to impaired T cell activation. Used in the treatment of myeloproliferative neoplasms and psoriasis. Anticancer agent. Shown to induce apoptosis and autophagy. Potent and selective inhibitor of HIV-1 replication and virus reactivation in vitro. It is investigated against the spread of the SARS-CoV-2 (COVID-19).

MCC950 (Free base)

B1031-1
EUR 153

MCC950 (Free base)

B1031-5
EUR 457

Apatinib (Free base)

B1613-25
EUR 414

Apatinib (Free base)

B1613-5
EUR 142

Carubicin (Free base)

B1853-1
EUR 153

Carubicin (Free base)

B1853-5
EUR 457

Anlotinib, free base

B2156-25
EUR 588

Anlotinib, free base

B2156-5
EUR 185

FIPI (free base)

B2372-25
EUR 631

FIPI (free base)

B2372-5
EUR 196

Terbinafine (Free base)

B2423-250
EUR 207

Terbinafine (Free base)

B2423-50
EUR 120

PLX5622 (free base)

B2965-25 25 mg
EUR 753

PLX5622 (free base)

B2965-5 5 mg
EUR 227

THZ1 (Free base)

9664-25
EUR 1023

THZ1 (Free base)

9664-5
EUR 294

Vatalanib, Free Base

2026-25
EUR 305

Vatalanib, Free Base

2026-5
EUR 126

Erlotinib, Free Base

2048-100
EUR 158

Erlotinib, Free Base

2048-1000
EUR 387

Sunitinib, Free base

2097-100
EUR 191

Sunitinib, Free base

2097-1000
EUR 501

Sunitinib, Free base

2097-25
EUR 115

Lapatinib, Free base

2138-100
EUR 387

Lapatinib, Free base

2138-25
EUR 191

Ruxolitinib, Free base

2139-100 Ask for price

Ruxolitinib, Free base

2139-25
EUR 533

Ruxolitinib, Free base

2139-5
EUR 207

Imatinib, Free base

2141-100
EUR 147

Imatinib, Free base

2141-1000
EUR 419

Linsitinib, Free base

2294-25
EUR 566

Linsitinib, Free base

2294-5
EUR 185

Tipifarnib, Free base

2296-1
EUR 142

Tipifarnib, Free base

2296-5
EUR 414

Vismodegib

HY-10440 10mM/1mL
EUR 126

Vismodegib

20-abx076843
  • EUR 314.00
  • EUR 244.00
  • 25 mg
  • 5 mg

Vismodegib

20-abx182703
  • EUR 356.00
  • EUR 620.00
  • 100 mg
  • 1 g

JTV-519 (free base)

HY-15293A 5mg
EUR 567

RGB-286638 (free base)

HY-15504A 100mg
EUR 2804

DOV-216,303 (Free Base)

HY-18332C 10mM/1mL
EUR 492

SB-334867 (free base)

HY-10895A 10mg
EUR 215

SNT-207858 (free base)

HY-11030A 10mg
EUR 911

APX-115 (free base)

HY-120801A 5mg
EUR 223

LY-2584702 (free base)

HY-12493 5mg
EUR 165

Genz-123346 (free base)

HY-12744 10mM/1mL
EUR 189

YHO-13351 (free base)

HY-12758A 10mM/1mL
EUR 176

FK-448 Free base

HY-100193 10mg
EUR 1887

KW-8232 free base

HY-100304 10mg
EUR 5018

YM-53601 free base

HY-100313 1mg
EUR 1559

AV-412 (free base)

HY-10346A 5mg
EUR 173

CP-319340(free base)

HY-U00270 5mg
EUR 877

Staurosporine, >99% Free Base

BC090-001 1mg
EUR 246

Staurosporine, >99% Free Base

BC090-005 5mg
EUR 340

Vandetanib, >99% Free Base

BC098-025 25mg
EUR 232

Vismodegib free base